Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and its wholly owned subsidiary Canopy Health Innovations Inc. has announced this morning that they been approved by the Veterinary Drug Directorate of Health Canada to research the effectiveness of the non-psychoactive cannabinoid cannabidiol (“CBD”) to treat anxiety in pets.
Numerous studies has been released over the past few years in relation to CBD’s effectiveness to reduce anxiety in humans and animals. Canopy Animal Health, a company under the umbrella of Canopy Growth, will be in charge of the study. The company focuses on the R&D of safe and effective products that utilizes natural cannabinoid extracts to improve the health of dogs, cats, and horses.
By conducting this research with approval from the Veterinary Drug Directorate of Health Canada, Canopy Growth will be positioning itself to launch a series of animal based pharmaceutical grade products to consumers. According to market researcher Packaged Facts, retail sales for pet supplements and nutraceutical treats in the U.S. continued to grow throughout 2017, to $1.6 billion.
The product formulations being developed by the company for the trials will be manufactured in Canopy Growth Corps. GMP-certified production facility in Smiths Falls, Ontario. Marc Wayne, Managing Director, Canopy Health Innovations gave this statement in the press release:
“Our passion to create safe and effective products for animals is driven by the love we share for our pets. The use of natural-occurring cannabinoids as a therapy for companion animals is a logical new forefront of medical discovery and the research we are working on at CAH is world leading. These trial approvals mark a significant milestone on the journey of making cannabis-based drugs accepted and recommended by veterinarians.”
You may be interested
CashCropToday | Joint Venture Interviews Justin Braune Part 1Ricky M - September 18, 2018
In this episode of Joint Venture, Michael Parker sits down with Justin Braine, Blunt Capital Co. Advisor, to discuss bridging the gap between Cannabis & Hemp Entrepreneurs…
CannTrust Completes First Shipment of Cannabis Oil to Denmark Partner STENOCAREEditor - September 18, 2018
CannTrust Holdings Inc. (TSX :TRST ) announced this morning that the company has completed its first international shipment of cannabis oils based products to STENOCARE, a Danish company…
Canopy Growth’s Tweed Farms Receives Additional Licensing for Cannabis ProductionEditor - September 17, 2018
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) announced this morning that their Tweed Farms cannabis cultivation operation has received an amendment to their license which will approve…